Olin (OLN)
(Delayed Data from NYSE)
$48.04 USD
+0.82 (1.74%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $44.00 -4.04 (-8.41%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum D VGM
Olin (OLN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$57.93 | $75.00 | $41.00 | 22.68% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Olin comes to $57.93. The forecasts range from a low of $41.00 to a high of $75.00. The average price target represents an increase of 22.68% from the last closing price of $47.22.
Analyst Price Targets (14)
Broker Rating
Olin currently has an average brokerage recommendation (ABR) of 2.41 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.41 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 30.77% and 7.69% of all recommendations. A month ago, Strong Buy made up 30.77%, while Buy represented 7.69%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 7 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.41 | 2.41 | 2.41 | 2.31 | 2.31 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/29/2024 | Piper Sandler | Charles N Neivert | Strong Buy | Strong Buy |
4/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
4/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
4/4/2024 | Not Identified | Not Identified | Hold | Hold |
4/3/2024 | Wells Fargo Securities | Michael J Sison | Hold | Hold |
1/30/2024 | Goldman Sachs | Duffy Fischer | Hold | Hold |
1/11/2024 | UBS | Joshua Spector | Hold | Hold |
9/5/2023 | Vertical Research Partners | Kevin W Mccarthy | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.41 |
ABR (Last week) | 2.41 |
# of Recs in ABR | 13 |
Average Target Price | $57.93 |
LT Growth Rate | 44.70% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 236 of 252 |
Current Quarter EPS Est: | 0.70 |